{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:40:00Z","timestamp":1790008800986,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejps.2022.106265","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T02:19:27Z","timestamp":1658197167000},"page":"106265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Columbus' egg: Oral drugs are absorbed in finite time"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2375-0552","authenticated-orcid":false,"given":"P.","family":"Macheras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Tsekouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106265_bib0001","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1208\/s12248-016-9953-7","article-title":"A quantitative review and meta-models of the variability and factors affecting oral drug absorption-part II: gastrointestinal transit time","volume":"18","author":"Abuhelwa","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2022.106265_bib0002","series-title":"Revising the assessment of bioequivalence in the light of finite absorption time concept: The axitinib case. Poster submitted to 30th PAGE meeting","author":"Alimpertis","year":"2022"},{"key":"10.1016\/j.ejps.2022.106265_bib0003","unstructured":"Center for Drug Evaluation and Research, 2002. Digoxin Bioequivalency Review 76268. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/anda\/2002\/76268_Digoxin_Bioeqr.pdf."},{"key":"10.1016\/j.ejps.2022.106265_bib0004","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijpharm.2019.05.041","article-title":"BCS and BDDCS: beyond guidelines (Invited review)","volume":"566","author":"Charalabidis","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2022.106265_bib0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s11095-021-03078-w","article-title":"Revising pharmacokinetics of oral drug absorption: II bioavailability-bioequivalence considerations","volume":"38","author":"Chryssafidis","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106265_bib0006","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-022-03230-0","article-title":"Re-writing oral pharmacokinetics using physiologically based finite time pharmacokinetic (PBFTPK) models","volume":"39","author":"Chryssafidis","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106265_bib0007","series-title":"Der Blutspiegel. Kinetik der Konzentrationsverl\u00e4ufe in der Kreislauffl\u00fcssigkeit","author":"Dost","year":"1953"},{"key":"10.1016\/j.ejps.2022.106265_bib0008","first-page":"142","article-title":"Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives","volume":"35","author":"Endrenyi","year":"1997","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2022.106265_bib0009","unstructured":"European medicines agency, 2010. Committee for medicinal products for human use (CHMP) guideline on the investigation of bioequivalence. London."},{"key":"10.1016\/j.ejps.2022.106265_bib0010","first-page":"FR 61011","article-title":"Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system","volume":"82","year":"2017","journal-title":"Guidance Ind."},{"key":"10.1016\/j.ejps.2022.106265_bib0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14366\/usg.15020","article-title":"Altered Doppler flow patterns in cirrhosis patients: an overview","volume":"35","author":"Iranpour","year":"2016","journal-title":"Ultrasonography"},{"key":"10.1016\/j.ejps.2022.106265_bib0012","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/jps.2600640921","article-title":"Comparative bioavailabilities from truncated blood level curves","volume":"64","author":"Lovering","year":"1975","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106265_bib0013","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11095-019-2633-4","article-title":"On an unphysical hypothesis of Bateman equation and its implications for pharmacokinetics","volume":"36","author":"Macheras","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106265_bib0014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11095-020-02894-w","article-title":"Revising pharmacokinetics of oral drug absorption: I models based on biopharmaceutical\/physiological and finite absorption time concepts","volume":"37","author":"Macheras","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106265_bib0015","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1124\/dmd.115.065920","article-title":"Physiologically Based Pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification","volume":"43","author":"Sager","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2022.106265_bib0016","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/bmj.4.5885.132","article-title":"Pharmacokinetics of digoxin: interpreting bioavailability","volume":"4","author":"Sanchez","year":"1973","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejps.2022.106265_bib0017","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejps.2013.05.019","article-title":"In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim","volume":"49","author":"Sj\u00f6gren","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106265_bib0018","doi-asserted-by":"crossref","unstructured":"Sugano, K., 2012. Biopharmaceutics modeling and simulations: theory, Practice, Methods, and Applications.","DOI":"10.1002\/9781118354339"},{"key":"10.1016\/j.ejps.2022.106265_bib0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5599\/admet.923","article-title":"Lost in modelling and simulation?","volume":"9","author":"Sugano","year":"2021","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejps.2022.106265_bib0020","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11095-021-03121-w","article-title":"Re-examining digoxin bioavailability after half a century: time for changes in the bioavailability concepts","volume":"38","author":"Tsekouras","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106265_bib0021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00280-017-3455-x","article-title":"Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a 14C-microtracer and therapeutic dose in cancer patients","volume":"81","author":"van Andel","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2022.106265_bib0022","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1124\/dmd.116.069906","article-title":"The absolute bioavailability and effect of food on the pharmacokinetics of odanacatib: a stable-label I.V.\/oral study in healthy postmenopausal women","volume":"44","author":"Zajic","year":"2016","journal-title":"Drug Metab. Dispos."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:05:13Z","timestamp":1760529913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722001506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"alternative-id":["S0928098722001506"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106265","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Columbus' egg: Oral drugs are absorbed in finite time","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106265"}}